miR-342-3p, which was revealed to interact with NFAM1 in our work, has been found to be differently expressed in blood-based miRNA profiles of cardiac amyloidosis, dilated cardiomyopathies, and heart failure in CVD research studies [41–43]. Here, NFAM1 is linked to dilated cardiomyopathy.